Related Experiment Video
Updated: Mar 25, 2026

Evaluating the Angiogenetic Properties of Ovarian Cancer Stem-Like Cells using the Three-Dimensional Co-Culture System, NICO-1
Published on: December 5, 2020
Nitric oxide signaling in human ovarian cancer: A potential therapeutic target
Ahmed El-Sehemy1, Lynne-Marie Postovit2, YangXin Fu3
1Department of Oncology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada; Department of Laboratory Medicine and Pathobiology, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
Abstract:
Ovarian cancer is the leading cause of death due to gynecologic malignancies worldwide. Current therapy regimens are ineffective to treat advanced ovarian cancers, presenting a need to develop novel therapeutic strategies. Nitric oxide (NO) is a multifunctional gaseous molecule that is generated by cancer, stromal and endothelial cells and plays a multifaceted role in cancer biology through multiple mechanisms. Accumulating evidence suggests that NO signaling is involved in multiple aspects of ovarian cancer, including growth, apoptosis, cancer-stromal cell interaction, angiogenesis and response to chemotherapy. This review will discuss the experimental and clinical evidence of the involvement of NO signaling in ovarian cancer and the therapeutic potential of targeting NO signaling in ovarian cancer.
Insights
Nitric oxide (NO) plays a key role in ovarian cancer development and progression. Targeting NO signaling offers a promising new therapeutic strategy for advanced ovarian cancers.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Ovarian cancer is a leading cause of gynecologic cancer mortality globally.
- Existing treatments for advanced ovarian cancer are often ineffective, necessitating novel therapeutic approaches.
Purpose of the Study:
- To review the role of nitric oxide (NO) signaling in ovarian cancer.
- To explore the therapeutic potential of targeting NO signaling for ovarian cancer treatment.
Main Methods:
- Literature review of experimental and clinical studies.
- Analysis of NO's multifaceted roles in cancer biology.
Main Results:
- Nitric oxide (NO) is implicated in ovarian cancer growth, apoptosis, angiogenesis, and chemotherapy response.
- NO signaling influences interactions between cancer and stromal cells.
Conclusions:
- NO signaling is integral to ovarian cancer progression.
- Targeting NO pathways presents a viable strategy for novel ovarian cancer therapies.
Related Concept Videos
Nitric Oxide Signaling Pathway
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
mTOR Signaling and Cancer Progression
Non-Canonical Wnt Signaling Pathways

